Cell Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
11.41
|
|
Average Rating
|
4.78
|
|
# Strong Buys
|
7
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.16
|
-0.13
|
0.03
|
18.75%
|
|
2022-06-30
|
-0.20
|
-0.21
|
-0.01
|
-5.00%
|
|
2022-03-31
|
-0.41
|
-0.37
|
0.04
|
9.76%
|
|
2021-12-31
|
-0.28
|
-0.38
|
-0.10
|
-35.71%
|
|
2021-09-30
|
-0.25
|
-0.26
|
-0.01
|
-4.00%
|
|
2021-06-30
|
-0.21
|
-0.21
|
0.00
|
0.00%
|
|
2021-03-31
|
-0.22
|
-0.23
|
-0.01
|
-4.55%
|
|
2020-12-31
|
-0.16
|
-0.20
|
-0.04
|
-25.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.71
|
|
2021-12-31
|
-1.08
|
|
2020-12-31
|
-0.74
|
|
2019-12-31
|
-0.69
|
|
2018-12-31
|
-0.53
|
|
2017-12-31
|
-1.29
|
|
2016-12-31
|
-1.83
|
|
2015-12-31
|
-6.70
|
|
2014-12-31
|
-5.27
|
|
2013-12-31
|
-4.70
|
|
2012-12-31
|
-23.88
|
|
2011-12-31
|
-37.50
|
|
2010-12-31
|
-63.00
|
|
2009-12-31
|
-75.79
|
|
2008-12-31
|
-4875.00
|
|
2007-12-31
|
-8400.00
|
|
2006-12-31
|
-15480.00
|
|
2005-12-31
|
-19080.00
|
|
2004-12-31
|
-36720.00
|
|
2003-12-31
|
-46800.00
|
|
2002-12-31
|
-37560.00
|
|
2001-12-31
|
-28920.00
|
|
2000-12-31
|
-59648.62
|
|
1997-12-31
|
-21960.00
|